RecruitingNot Applicable

Trial Comparing Multiport RObotic and Laparoscopic Surgery for Elective Colorectal Resections in IBD Patients (ACRO-IBD)

Belgium110 participantsStarted 2025-10-01

Plain-language summary

The aim of this study is to better understand whether robotic surgery leads to better outcomes than laparoscopy in terms of complications, recovery and quality of life.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures
✓. At least 18 years of age at the time of signing the Informed Consent Form (ICF)
✓. Diagnosed with IBD and eligible for elective minimally invasive colorectal surgery, including:
✓.4 Ileocecal/ileocolic resections 1.5 Segmental colectomies 1.6 Total colectomy 1.7 Proctocolectomy 1.8 Proctectomy
✓. Procedures involving primary anastomosis or temporary or permanent stoma creation
✓. Suitable for minimally invasive surgery

Exclusion criteria

✕. Non IBD patients
✕. Urgent surgery (\<24 hours from hospital admission)
✕. Not suitable for minimally invasive surgery
✕. Ileoanal pouch construction

What they're measuring

Postoperative morbidity

Timeframe: During the first 90 days postoperatively

Trial details

NCT IDNCT07230262

SponsorUniversitaire Ziekenhuizen KU Leuven

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2028-05-01

Contact for this trial

Isabelle Terrasson

+3216340837 isabelle.terrasson@uzleuven.be

View on ClinicalTrials.gov More IBD - Inflammatory Bowel Disease trials